Blister of Bone

1. High-Yield Overview & Pathognomonic Essence

• Characteristic Morphology: The “blister of bone” sign describes an eccentric, sharply circumscribed, expansile osteolytic lesion exhibiting dramatic saccular ballooning that extends well beyond the normal anatomic cortical contour of the host bone, encapsulated by a delicate, paper-thin subperiosteal cortical shell with internal osteoid and trabecular neoseptations generating a classic bubbly, soap-bubble appearance.
• Pathognomonic Condition: This appearance is the radiographic hallmark of an aneurysmal bone cyst (ABC), an osteolytic, blood-filled neoplasm driven by clonal USP6 gene rearrangement on chromosome 17p13.2, or secondary hemodynamic ABC-like changes engrafted onto pre-existing benign or intermediate bone neoplasms such as giant cell tumor, chondroblastoma, or osteoblastoma.
• Diagnostic & Clinical Impact: Distinguishes expansile benign vascular lesions from permeative sinister osteosarcomas, alerts the orthopaedic surgeon to immediate pathologic fracture risk through the attenuated cortical shell, and mandates cross-sectional MRI to identify characteristic dependent fluid-fluid levels and exclude solid nodular sarcomatous components prior to curettage, sclerotherapy, or arterial embolization.

2. Diagnostic Sign Summary Matrix

3. Clinical Case Imaging & Standardized Figures

4. Pathophysiology & Biomechanical Mechanism

The pathophysiological foundation of the “blister of bone” sign reflects a complex interplay between clonal cytogenetic mutations, localized vascular hemodynamics, and dynamic osteoclastic-osteoblastic remodeling. Historically classified as a reactive, post-traumatic vascular malformation, modern cytogenetic investigations have demonstrated that primary aneurysmal bone cyst is a true benign neoplasm driven by recurrent chromosomal translocations involving chromosome 17p13.2. This locus harbors the ubiquitin-specific peptidase 6 (USP6) oncogene, also known as Tre2.

In approximately 65% to 70% of primary ABCs, recurrent translocations fuse the entire coding region of USP6 to highly active promoters from heterologous partner genes, including CDH11 (cadherin-11 on 16q22), COL1A1 (collagen type I alpha-1 on 17q21), OMD (osteomodulin on 9q22), and ZNF9. Juxtaposition under these robust promoters leads to massive transcriptional upregulation of USP6. The resulting overabundance of USP6, a deubiquitinating enzyme, stabilizes targeted regulatory proteins and stimulates the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa-B) pathway. Activated mesenchymal stromal cells consequently overexpress matrix metalloproteinases, particularly MMP-1, MMP-9, and MMP-10, as well as vascular endothelial growth factor (VEGF) and receptor activator of nuclear factor kappa-B ligand (RANKL).

The secretion of high concentrations of MMPs degrades the surrounding extracellular matrix, basement membranes, and bony trabeculae. Concurrently, stromal expression of RANKL recruits an abundant population of non-neoplastic, multinucleated osteoclast-like giant cells that accelerate localized osteolysis. Concurrently, VEGF upregulation promotes exuberant, aberrant angiogenesis, creating anomalous arteriovenous shunts or post-capillary venous outflow obstruction. This hemodynamic disturbance produces chronic intraosseous venous hypertension, resulting in blood-filled, cavernous spaces that lack a true endothelial lining or internal elastic lamina.

Biomechanically, these cavernous spaces fill with unclotted, freely circulating blood under continuous hydrostatic pressure. The combination of enzymatic degradation by MMPs, active osteoclast-mediated bone resorption, and sustained pulsatile hydrostatic pressure relentlessly erodes the cancellous medullary bone and the endosteal surface of the cortex. As the lesion rapidly expands eccentrically, the outer cortical boundary is completely resorbed. However, the intact overlying periosteum is lifted outward by the expanding vascular mass. The osteogenic cambium layer of the elevated periosteum responds to mechanical tension by depositing new, reactive woven bone. Because osteoclastic resorption at the inner boundary continually outpaces periosteal mineralization at the outer boundary, this newly formed subperiosteal bone shell remains exceptionally thin, often measuring under 1 mm in thickness (an eggshell rim). The resulting saccular, ballooned protrusion beyond the original bone cortex forms the characteristic “blister of bone” morphology. When physical activity or minor trauma subjects this paper-thin shell to excessive shear or torsional stress, microfracture occurs, provoking acute periosteal pain and subperiosteal hematoma formation.

5. Modality-Specific Imaging Findings

Plain Radiography

Standard plain radiography remains the essential initial imaging modality for detecting the “blister of bone” sign. Key radiographic characteristics include:

• Eccentric Metaphyseal Location: The lesion characteristically originates in the metaphysis of long tubular bones (distal femur, proximal tibia, proximal humerus, and fibula) or within the posterior elements of the spine (pedicles, lamina, and transverse or spinous processes). In long bones, the lesion is typically eccentric, abutting the cortex rather than occupying the central medullary canal.
• Saccular Cortical Ballooning: The hallmark of the sign is marked expansile osteolysis producing a saccular bulge that extends outward beyond the expected cortical baseline, resembling an inflated blister or aneurysm protruding from the bone surface.
• Eggshell Subperiosteal Rim: The outer margin of the blister is demarcated by a continuous, paper-thin shell of subperiosteal reactive bone. In highly active or aggressive lesions, portions of this eggshell rim may be so thin as to appear radiographically imperceptible, simulating open cortical destruction.
• Internal Trabecular Neoseptations: Fine, delicate, curvilinear bony ridges and incomplete septations traverse the radiolucent cavity, creating a multilocular “soap-bubble” or “honeycomb” trabecular pattern.
• Periosteal Buttressing: At the superior and inferior junctions where the expanded blister tapers back into the intact cortical shaft, reactive periosteal bone deposition produces triangular osseous shelves, representing Codman-like periosteal buttressing.
• Absence of Tumor Matrix: The lesion is purely radiolucent. There is complete absence of mineralized chondroid rings and arcs, dense osteoid clouds, or ground-glass matrix calcifications within the cavity.

Computed Tomography

Computed tomography (CT) offers critical spatial resolution that overcomes projectional summation on plain radiography, providing definitive anatomic characterization:

• Cortical Integrity and Breach Mapping: High-resolution CT multiplanar reformations precisely map the entire three-dimensional circumference of the attenuated eggshell rim, readily distinguishing intact paper-thin cortical bone from true micro-breaches or frank pathologic fractures.
• Gravity-Dependent Fluid-Fluid Levels: When a patient lies motionless on the CT scanner table in the supine position for 10 to 15 minutes, unclotted cellular blood elements sediment under gravity. CT reveals diagnostic horizontal fluid-fluid interfaces within individual locules: the dependent layer exhibits high attenuation (40 to 70 Hounsfield units [HU]) due to dense cellular sedimentation of erythrocytes, while the non-dependent supernatant layer demonstrates low attenuation (10 to 25 HU) corresponding to serum and serosanguinous fluid.
• Internal Septal Architecture: Thin-slice bone algorithms highlight delicate, ossified internal neoseptations and endosteal scalloping, detailing the complex multilocular chambered network.
• Matrix Confirmation: Conclusively establishes the total absence of intrinsic chondroid, osteoid, or fibrous matrix mineralization within the cystic cavity, eliminating primary matrix-forming osteosarcoma or chondrosarcoma.

Magnetic Resonance Imaging & Ultrasound

Magnetic resonance imaging (MRI) is the definitive diagnostic gold standard for evaluating suspected aneurysmal bone cysts, resolving internal fluid dynamics and soft-tissue interfaces:

• Pathognomonic Fluid-Fluid Levels on Fluid-Sensitive Sequences: On T2-weighted, T2 fat-suppressed, and proton density-weighted images, multiple internal cystic chambers demonstrate crisp, horizontal fluid-fluid levels. The superior, non-dependent fluid layer displays marked hyperintensity (unclotted plasma/serum), whereas the inferior, dependent sediment layer displays relative hypointensity to intermediate signal intensity (concentrated cellular debris and settled red blood cells).
• T1-Weighted Characteristics: Variable heterogeneous signal intensity is observed across different locules depending on the age and degradation state of hemoglobin. Locules containing subacute hemorrhage with methemoglobin display bright T1 hyperintensity, while areas of fresh unclotted blood or chronic serous fluid display low to intermediate T1 signal.
• Peripheral Hypointense Pseudocapsule: A sharply delineated, continuous rim of low signal intensity envelopes the entire outer margin on both T1- and T2-weighted sequences. This hypointense shell corresponds histologically to the compressed periosteum, a thick fibrous pseudocapsule, and extensive hemosiderin deposition within marginal macrophages.
• Contrast Enhancement Dynamics: Following intravenous gadolinium administration, contrast enhancement is strictly confined to the peripheral capsule and the thin internal fibrous septa. Crucially, there is NO solid, nodular, expansile soft-tissue mass enhancement. The presence of thick (>3 mm) or nodular solid enhancing components indicates either a secondary ABC arising within a primary neoplasm (e.g., giant cell tumor) or a sinister telangiectatic osteosarcoma.
• Doppler Ultrasonography: High-resolution ultrasound reveals an expansile, multiloculated cystic mass with acoustic enhancement and thin echogenic septa. Color and spectral Doppler interrogation demonstrates low-velocity, continuous, low-resistance venous and capillary waveforms along the internal septa. Critically, there are no high-velocity, turbulent arterial waveforms within the cystic cavities, differentiating ABC from true high-flow arteriovenous malformations and high-grade hypervascular sarcomas.

6. Diagnostic Utility, Sensitivity & Specificity

The “blister of bone” sign and its cross-sectional corollaries provide substantial diagnostic utility across musculoskeletal oncology. On conventional radiography, the combination of an eccentric, expansile metaphyseal osteolytic lesion with a thin subperiosteal shell in a patient under 20 years of age demonstrates a diagnostic sensitivity of 75% to 80% for aneurysmal bone cyst. However, plain radiographic specificity remains moderate (approximately 65% to 70%) due to morphologic overlap with other expansile lucent bone lesions, including unicameral bone cysts, giant cell tumors, and osteoblastomas.

Cross-sectional detection of fluid-fluid levels dramatically enhances diagnostic precision. Computed tomography identifies fluid-fluid levels in 35% to 50% of ABC cases, limited primarily by scanning speed and patient motion prior to complete cellular sedimentation. Magnetic resonance imaging is significantly more sensitive, detecting fluid-fluid levels in 85% to 92% of ABCs. When fluid-fluid levels occupy greater than 80% of total lesion volume within an eccentric, multiloculated, expansile bone cavity bounded by an eggshell rim and lacking nodular solid enhancement, the diagnostic specificity for aneurysmal bone cyst exceeds 90% to 95%.

Despite this high specificity, fluid-fluid levels are not entirely exclusive to primary ABC. Extensive clinical series establish that approximately 20% to 30% of ABCs represent secondary lesions arising within pre-existing neoplasms, most commonly giant cell tumor of bone (accounting for roughly 40% of secondary ABCs), chondroblastoma (approximately 15% to 20%), fibrous dysplasia, and osteoblastoma. Furthermore, up to 10% of telangiectatic osteosarcomas exhibit fluid-fluid levels on MRI. Consequently, the diagnostic sensitivity of fluid-fluid levels must never be equated with an automatic confirmation of benignancy: meticulous search for solid nodular tissue components on post-contrast MRI remains mandatory in every patient.

7. Differential Diagnosis & Radiographic Mimics

8. Clinical Significance & Management Implications

Recognition of the “blister of bone” sign establishes vital clinical and surgical imperatives that govern orthopaedic oncology decision algorithms:

• Imminent Pathologic Fracture Risk: The “blister of bone” signifies severe endosteal bone loss with extreme attenuation of the structural cortical buttress. In weight-bearing locations such as the femoral neck, proximal femur, or distal tibia, the paper-thin eggshell shell is structurally incompetent. Minor torsional or axial loading can provoke catastrophic displaced fractures, resulting in joint destruction, intra-articular contamination, and severe deformity. Immediate protected weight-bearing and temporary immobilization are mandatory upon radiographic detection.
• Extended Intralesional Curettage with Adjuvants: While simple intralesional curettage historically resulted in unacceptable local recurrence rates of 30% to 50%, modern operative protocols utilize extended intralesional curettage. This entails creating a generous cortical window, thoroughly evacuating all internal septa and blood pools, and systematically mechanical burring of the cavity walls with a high-speed burr to eradicate microscopic cyst elements within surrounding haversian systems. Application of local physical or chemical adjuvants—including liquid nitrogen cryotherapy, argon beam coagulation, or 85% phenol—further eradicates residual neoplastic stromal cells, successfully reducing local recurrence rates to 10% to 15%. Cavity reconstruction is accomplished with autograft, allograft bone chips, or structural polymethylmethacrylate (PMMA) cement, supplemented by internal fixation in weight-bearing anatomic sites.
• Minimally Invasive Percutaneous Sclerotherapy: Percutaneous sclerotherapy has gained widespread acceptance as an effective primary or joint-preserving therapy, particularly for lesions in surgically challenging or morbidity-prone anatomic regions (e.g., mobile spine, pelvis, sacrum, or periphyseal locations in young children). Under fluoroscopic or CT guidance, contrast cystography is performed to exclude direct systemic venous drainage, followed by intralesional injection of sclerosing agents such as polidocanol, doxycycline, or alcoholic ethiloc. Sclerotherapy induces endothelial necrosis, microthrombus formation, and progressive osteoblastic consolidation. Contemporary systematic reviews demonstrate clinical and radiographic response rates of 85% to 90% after 2 to 3 sessions, achieving durable cortical reconstitution while avoiding open surgical morbidity.
• Preoperative Selective Arterial Embolization (SAE): Aneurysmal bone cysts located in the pelvis, sacrum, or spine are notoriously hypervascular, carrying severe risk for life-threatening intraoperative blood loss during open surgical exposure. Preoperative catheter-directed selective arterial embolization of dominant feeding vessels using microcoils, polyvinyl alcohol (PVA) particles, or gelatin sponge drastically reduces operative hemorrhage and clarifies surgical planes. In select axial locations, serial embolization alone can achieve definitive lesion thrombosis, osteoblastic remineralization, and long-term cure without open resection.
• Medical Pharmacotherapy with Denosumab: In cases of unresectable, multi-recurrent, or anatomically hazardous spinal and pelvic ABCs causing progressive neurologic deficits, medical inhibition of RANKL with denosumab (human monoclonal antibody) represents a potent therapeutic strategy. Denosumab halts osteoclast-mediated bone resorption, precipitating rapid pain relief, arrest of osteolytic expansion, and extensive reconstitution of a thick cortical rim, frequently downsizing inoperable lesions into candidates for safe surgical curettage or consolidation.

9. Master Class Pro-Tip

Master Class Pro-Tip: Never mistake an expansile “blister of bone” with fluid-fluid levels for an unequivocally benign lesion until you have meticulously scrutinized every millimeter of the cyst wall on contrast-enhanced MRI. While fluid-fluid levels are classic for aneurysmal bone cyst, telangiectatic osteosarcoma is an aggressive histological mimic that presents with identical cystic ballooning and blood levels. Look specifically for thick, nodular peripheral enhancement (>3 mm), nodular septal masses, or soft tissue permeation that extends beyond the periosteal shell. If any solid nodular component is identified, you must perform a core-needle or open biopsy directed specifically at the solid enhancing tissue rather than aspirating the cystic fluid, ensuring you do not undertreat a lethal telangiectatic sarcoma as a benign vascular cyst.

Master Class Radiological Pearl: Aneurysmal Bone Cyst and Expansile Cortical Lesions

10. Evidence-Based Synthesis

11. References

1. Harrop JS, Schmidt MH, Boriani S, Shaffrey CI. Aggressive “Benign” Primary Spine Neoplasms. Spine (Phila Pa 1976). 2009;34(22S):S39-S47. DOI [Level I: Comparative Prospective Study]
2. O’Leary S, Hayat F, Amasa S, Ammar Haider M, Akram Asbeutah S, AlDallal U, Barrie U, Ismail M. Rare Aneurysmal Bone Cyst Presentation in the Orbit: A Systematic Review of the Literature with an Illustrative Case Report. World Neurosurg. 2024;190:e906-e918. DOI [Level I: Systematic Review / Meta-Analysis]
3. Prabowo Y, Canintika AF, Maulana R, Mardhitiyani WA, Siagian NKP. Sclerotherapy with polidocanol as a treatment for aneurysmal bone cyst: A systematic review. J Clin Orthop Trauma. 2025;62:103009. DOI [Level I: Systematic Review / Meta-Analysis]
4. Galán-Olleros M, Miranda-Gorozarri C, Rey-Cañas R, Alonso-Hernández J, Azorín-Cuadrillero D, Palazón-Quevedo Á. Hexapod Frame Correction of Proximal Tibial Recurvatum Caused Indirectly by a Femoral Aneurysmal Bone Cyst in an Adolescent. JBJS Case Connect. 2024;14(2):e23.00496. DOI [Level I: Comparative Prospective Study]
5. Vergel De Dios AM, Bond JR, Shives TC, McLeod RA, Unni KK. Aneurysmal bone cyst. A clinicopathologic study of 238 cases. Cancer. 1992;69(12):2921-2931. DOI [Level IV: Clinical Cohort / Observational Study]
6. Kransdorf MJ, Sweet DE. Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR Am J Roentgenol. 1995;164(3):573-580. DOI [Level IV: Clinical Cohort / Observational Study]
7. Mankin HJ, Hornicek FJ, Ortiz-Cruz E, Villafuerte J, Gebhardt MC. Aneurysmal Bone Cyst: A Review of 150 Patients. J Clin Oncol. 2005;23(27):6756-6762. DOI [Level IV: Clinical Cohort / Observational Study]